Jia Fei - Publications

Affiliations: 
University of California, San Diego, La Jolla, CA 

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Chavez C, Cruz-Becerra G, Fei J, Kassavetis GA, Kadonaga JT. The tardigrade damage suppressor protein binds to nucleosomes and protects DNA from hydroxyl radicals. Elife. 8. PMID 31571581 DOI: 10.7554/eLife.47682  0.96
2019 Wang W, Xu J, Limbo O, Fei J, Kassavetis GA, Chong J, Kadonaga JT, Russell P, Li B, Wang D. Molecular basis of chromatin remodeling by Rhp26, a yeast CSB ortholog. Proceedings of the National Academy of Sciences of the United States of America. PMID 30867290 DOI: 10.1073/pnas.1818163116  0.96
2019 Gu C, Liu Y, Yin Z, Yang J, Huang G, Zhu X, Li Y, Fei J. Discovery of the Oncogenic Parp1, a Target of bcr-abl and a Potential Therapeutic, in mir-181a/PPFIA1 Signaling Pathway. Molecular Therapy. Nucleic Acids. 16: 1-14. PMID 30825668 DOI: 10.1016/j.omtn.2019.01.015  0.6
2018 Fei J, Ishii H, Hoeksema MA, Meitinger F, Kassavetis GA, Glass CK, Ren B, Kadonaga JT. NDF, a nucleosome destabilizing factor that facilitates transcription through nucleosomes. Genes & Development. PMID 29759984 DOI: 10.1101/gad.313973.118  0.96
2018 Yin Z, Yang J, Ning R, Liu Y, Feng M, Gu C, Fei J, Li Y. Signal pathways, diseases, and functions associated with the miR-19a/92a cluster and the use of berberine to modulate the expression of this cluster in multiple myeloma cells. Journal of Biochemical and Molecular Toxicology. e22057. PMID 29687521 DOI: 10.1002/jbt.22057  0.6
2017 Khuong MT, Fei J, Cruz-Becerra G, Kadonaga JT. A simple and versatile system for the ATP-dependent assembly of chromatin. The Journal of Biological Chemistry. PMID 28982979 DOI: 10.1074/jbc.M117.815365  0.96
2016 Gu C, Li T, Yin Z, Chen S, Fei J, Shen J, Zhang Y. Integrative analysis of signaling pathways and diseases associated with the miR-106b/25 cluster and their function study in berberine-induced multiple myeloma cells. Functional & Integrative Genomics. PMID 27647143 DOI: 10.1007/s10142-016-0519-7  0.48
2016 Zhang F, Fei J, Sun M, Ping Q. Heparin modification enhances the delivery and tumor targeting of paclitaxel-loaded N-octyl-N-trimethyl chitosan micelles. International Journal of Pharmaceutics. PMID 27426109 DOI: 10.1016/j.ijpharm.2016.07.020  0.56
2016 Fei J, Cui XB, Wang JN, Dong K, Chen SY. ADAR1-Mediated RNA Editing, A Novel Mechanism Controlling Phenotypic Modulation of Vascular Smooth Muscle Cells. Circulation Research. PMID 27199464 DOI: 10.1161/CIRCRESAHA.116.309003  0.68
2016 Gu C, Feng M, Yin Z, Luo X, Yang J, Li Y, Li T, Wang R, Fei J. RalA, a GTPase targeted by miR‑181a, promotes transformation and progression by activating the Ras‑related signaling pathway in chronic myelogenous leukemia. Oncotarget. PMID 26967392 DOI: 10.18632/oncotarget.7987  0.48
2016 Khuong MT, Fei J, Ishii H, Kadonaga JT. Prenucleosomes and Active Chromatin. Cold Spring Harbor Symposia On Quantitative Biology. PMID 26767995 DOI: 10.1101/sqb.2015.80.027300  0.96
2015 Fei J, Torigoe SE, Brown CR, Khuong MT, Kassavetis GA, Boeger H, Kadonaga JT. The prenucleosome, a stable conformational isomer of the nucleosome. Genes & Development. 29: 2563-75. PMID 26680301 DOI: 10.1101/gad.272633.115  0.48
2015 Feng M, Luo X, Gu C, Li Y, Zhu X, Fei J. Systematic analysis of berberine-induced signaling pathway between miRNA clusters and mRNAs and identification of mir-99a ∼ 125b cluster function by seed-targeting inhibitors in multiple myeloma cells. Rna Biology. 12: 82-91. PMID 25826415 DOI: 10.1080/15476286.2015.1017219  0.48
2015 Feng M, Luo X, Gu C, Fei J. Seed targeting with tiny anti-miR-155 inhibits malignant progression of multiple myeloma cells. Journal of Drug Targeting. 23: 59-66. PMID 25185784 DOI: 10.3109/1061186X.2014.951653  0.48
2014 Wang L, Limbo O, Fei J, Chen L, Kim B, Luo J, Chong J, Conaway RC, Conaway JW, Ranish JA, Kadonaga JT, Russell P, Wang D. Regulation of the Rhp26ERCC6/CSB chromatin remodeler by a novel conserved leucine latch motif. Proceedings of the National Academy of Sciences of the United States of America. 111: 18566-71. PMID 25512493 DOI: 10.1073/pnas.1420227112  0.48
2014 Luo X, Gu J, Zhu R, Feng M, Zhu X, Li Y, Fei J. Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine. Bmc Systems Biology. 8: 82. PMID 25000828 DOI: 10.1186/1752-0509-8-82  0.6
2014 Ding Y, Wu M, Liu J, Wu C, Huang R, Zhu R, Fei J. Seed-targeting anti-miR-21 inhibiting malignant progression of retinoblastoma and analysis of their phosphorylation signaling pathways. Experimental Eye Research. 122: 1-8. PMID 24607444 DOI: 10.1016/j.exer.2014.02.017  0.6
2013 Luo X, Feng M, Zhu X, Li Y, Fei J, Zhang Y. VEGF depletion enhances bcr-abl-specific sensitivity of arsenic trioxide in chronic myelogenous leukemia. Hematology (Amsterdam, Netherlands). 18: 334-40. PMID 24129092 DOI: 10.1179/1607845413Y.0000000083  0.6
2013 Su Z, Shi Y, Xiao Y, Sun M, Ping Q, Zong L, Li S, Niu J, Huang A, You W, Chen Y, Chen X, Fei J, Tian J. Effect of octreotide surface density on receptor-mediated endocytosis in vitro and anticancer efficacy of modified nanocarrier in vivo after optimization. International Journal of Pharmaceutics. 447: 281-92. PMID 23396258 DOI: 10.1016/j.ijpharm.2013.01.068  0.56
2013 Fei J, Zhou L, Liu T, Tang XY. Pharmacophore modeling, virtual screening, and molecular docking studies for discovery of novel Akt2 inhibitors. International Journal of Medical Sciences. 10: 265-75. PMID 23372433 DOI: 10.7150/ijms.5344  0.36
2012 Fei J, Chen J. KIAA1530 protein is recruited by Cockayne syndrome complementation group protein A (CSA) to participate in transcription-coupled repair (TCR). The Journal of Biological Chemistry. 287: 35118-26. PMID 22902626 DOI: 10.1074/jbc.M112.398131  1
2012 Ding Y, Zhu X, Li Y, Fei J, Zhang Y. Targeted inhibition of VEGF-modulated survival and arsenic sensitivity in acute myeloid leukemia (AML). Hematology (Amsterdam, Netherlands). 17: 157-62. PMID 22664115 DOI: 10.1179/102453312X13376952196458  0.6
2012 Fei J, Li Y, Zhu X, Luo X. miR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML). Plos One. 7: e32834. PMID 22442671 DOI: 10.1371/journal.pone.0032834  0.6
2012 Zhu X, Li Y, Luo X, Fei J. Inhibition of small GTPase RalA regulates growth and arsenic-induced apoptosis in chronic myeloid leukemia (CML) cells. Cellular Signalling. 24: 1134-40. PMID 22330069 DOI: 10.1016/j.cellsig.2012.01.016  0.6
2011 Gu J, Zhu X, Li Y, Dong D, Yao J, Lin C, Huang K, Hu H, Fei J. miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines. Medical Oncology (Northwood, London, England). 28: 211-8. PMID 20143188 DOI: 10.1007/s12032-009-9413-7  0.6
2010 Li Y, Zhu X, Gu J, Hu H, Dong D, Yao J, Lin C, Fei J. Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis. Hematology (Amsterdam, Netherlands). 15: 215-21. PMID 20670480 DOI: 10.1179/102453310X12647083620840  0.6
2010 Wu M, Wang B, Fei J, Santanam N, Blough ER. Important roles of Akt/PKB signaling in the aging process. Frontiers in Bioscience (Scholar Edition). 2: 1169-88. PMID 20515848  0.52
2010 Li Y, Zhu X, Gu J, Dong D, Yao J, Lin C, Huang K, Fei J. Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis. Cancer Science. 101: 948-54. PMID 20148895 DOI: 10.1111/j.1349-7006.2010.01489.x  0.6
2010 Hu H, Li Y, Gu J, Zhu X, Dong D, Yao J, Lin C, Fei J. Antisense oligonucleotide against miR-21 inhibits migration and induces apoptosis in leukemic K562 cells. Leukemia & Lymphoma. 51: 694-701. PMID 20141427 DOI: 10.3109/10428191003596835  0.6
Show low-probability matches.